Purchase Order 75N95022P00248
Award Date 4/27/22
Potential Completion Date 5/25/24
Potential Value $80K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, awarded a $34,450.00 firm-fixed-price purchase order contract to Optibrium Limited, a foreign-owned for-profit organization based in the United Kingdom. The contract is for a software and database subscription for the StarDrop product, which supports the National Center for Advancing Translational Sciences' (NCATS) drug discovery research capabilities. This sole-source award was made...
- This is a $82,823.54 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency of the National Institutes of Health (NIH), to Cresset Biomolecular Discovery LIMITED, a for-profit organization based in the United Kingdom. The contract is for a software license for 5 users to aid NCATS' chemists with 3D structure-activity relationship (SAR) analysis, generation of novel and diverse molecular structures using...
- This is a $19,327.07 firm fixed-price purchase order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Andor Technology, Inc., a foreign-owned for-profit provider of scientific equipment and software. The award is for the annual lease of Imaris, a specialized microscopy analysis software, to support the research activities of NINDS's Laboratory of Circuits, Synapses, and Molecular Signaling. This is a...
- The Department of Health and Human Services' National Institutes of Health's National Center for Advancing Translational Sciences awarded an $11,711 firm fixed price purchase order to Open Policy LTD for a one-year subscription to the Overton Policy Database. Open Policy LTD, located in Great Britain, will provide access to its database of scientific and medical literature under this contract through July 2024. The National Center for Advancing Translational Sciences seeks to accelerate the...
- The National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, awarded a $49,948.80 firm-fixed-price purchase order to Carl Zeiss Microscopy, LLC, a foreign-owned for-profit organization, to provide a 3D image software suite for automated end-to-end image pipeline analysis. This award was made under a brand-name only competition among authorized resellers, as the Zeiss Arivis Pro Analysis + VR ACA software is already...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Proteros Biostructures GMBH, a foreign-owned for-profit organization and manufacturer of goods. The contract is for $38,035.00 and is for x-ray structure analyses of eEF1A2 and c-Abl in complex with ligands. The contract was awarded on September 3, 2015 and has a completion date of September 7, 2016....
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $30,316.20 firm fixed price purchase order to Horizon Discovery Biosciences Limited, located in Great Britain, United Kingdom. The contract is for unspecified products or services to be delivered between July 12, 2023 and July 22, 2023 in support of NIH's efforts to enhance the development, testing, and implementation of translational sciences. Horizon...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order contract to Labvoice, Inc., a for-profit organization, on May 16, 2024. The contract has a potential value of $32,000.00 and a completion date of May 15, 2025. This award is not associated with any set-aside designation. The contract is for the provision of unspecified products or services to be performed in Potomac, Maryland.
- This firm-fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Nextmove Software LIMITED, a for-profit software company based in the United Kingdom. The $42,800 contract is for annual software licenses, maintenance, and perpetual licenses for Nextmove's HazELNut, LeadMine, CaffeineFix, SmallWorld, and Pistachio software products. These solutions...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,634.80 firm-fixed-price purchase order to National Instruments Corporation for a one-year renewal of a proprietary system design software license subscription. The original sole-source solicitation sought a 12-month license for software to perform custom algorithmic analysis of images from high-content screening devices and compound plate quality control,...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a Firm Fixed Price purchase order contract to Optibrium LIMITED, a foreign-owned for-profit organization, for a STARDROP SOFTWARE LICENSE. The contract has a potential value of $80,142.00 and a completion date of May 25, 2024. The contract is not set aside for any specific business type.
Generated 5/7/24, 12:12 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $27.3k | 5/6/24 | |
| P00001 | Exercise an Option | $27.2k | 5/1/23 | |
| Not listed | Not listed | $25.7k | 4/27/22 |